AD-203

· Addpharma Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AD-203, covering 2020-12-02 to 2020-12-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AD-203 [Phase 3]